The Pathology of Lupus Nephritis

Seminars in Nephrology

Volumn 27, Issue 1, 2007, Pages 22-34

  Schwartz, Melvin M ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

collapsing FSGS; immune complex disease; in situ immune complex disease; ISN RPS classification; pathology; podocytopathy; Systemic lupus erythematosus; thrombotic microangiopathy; TTP like; vasculitis

Indexed keywords

ANTIGEN ANTIBODY COMPLEX; ARTICLE; DISEASE CLASSIFICATION; GLOMERULUS CAPILLARY; HISTOPATHOLOGY; IMMUNE COMPLEX DISEASE; KIDNEY INJURY; LUPUS ERYTHEMATOSUS NEPHRITIS; NONHUMAN; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; PROGNOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; VASCULITIS; WORLD HEALTH ORGANIZATION;

ANIMALS; HUMANS; IMMUNE COMPLEX DISEASES; KIDNEY GLOMERULUS; LUPUS NEPHRITIS; PODOCYTES; THROMBOSIS;

EID: 33847280958     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2006.09.005     Document Type: Article

References (54)

1. Klemperer P., Pollack A.D., and Baehr G. Pathology of disseminated lupus erythematosus. Arch Pathol. 32 (1941) 569-631
2. Weening J.J., D'Agati V.D., Schwartz M.M., Seshan S.V., Alpers C.E., Appel G.B., et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 65 (2004) 521-530
3. Weening J.J., D'Agati V.D., Schwartz M.M., Seshan S.V., Alpers C.E., Appel G.B., et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 15 (2004) 241-250
4. Muehrcke R.C., Kark R.M., Pirani C.L., and Pollak V.E. Lupus nephritis: a clinical and pathologic study based on renal biopsies. Medicine 36 (1957) 1-146
5. Pollak V.E., Pirani C.L., and Schwartz F.D. The natural history of the renal manifestations of systemic lupus erythematosus. J Lab Clin Med. 63 (1964) 537-550
6. Baldwin D.S., Lowenstein J., Rothfield N.F., Gallo G., and McCluskey R.T. The clinical course of the proliferative and membranous forms of lupus nephritis. Ann Intern Med. 73 (1970) 929-942
7. Baldwin D.S., Gluck M.C., Lowenstein J., and Gallo G.R. Lupus nephritis. Clinical course as related to morphologic forms and their transitions. Am J Med. 62 (1977) 12-30
8. Churg J., and Sobin L.H. Lupus Nephritis. Renal disease, classification and atlas of glomerular diseases (1982), Igaku-Shoin, New York 127-149
9. Churg J., Bernstein J., and Glassock R.J. Lupus Nephritis. Renal disease. Classification and atlas of glomerular diseases (1995), Igaku-Shoin, New York 151-180
10. Corwin H.L., Schwartz M.M., and Lewis E.J. The importance of sample size in the interpretation of renal biopsy. Am J Nephrol. 8 (1988) 85-89
11. Feinstein A.R., Sosin D.M., and Wells C.K. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 312 (1985) 1604-1608
12. Koffler D., Agnello V., Thoburn R., and Kunkel H.G. Systemic lupus erythematosus: prototype of immune complex nephritis in man. J Exp Med. 134 (1971) 169s-179s
13. Hill G.S., Hinglais N., Tron F., and Bach J.F. Systemic lupus erythematosus. Morphologic correlations with immunologic and clinical data at the time of biopsy. Am J Med. 64 (1978) 61-79
14. Cameron J.S., Turner D.R., Ogg C.S., Williams D.G., Lessof M.H., Chantler C., et al. Systemic lupus with nephritis: a long-term study. QJM 48 (1979) 1-24
15. Dujovne I., Pollak V.E., Pirani C.L., and Dillard M.G. The distribution and character of glomerular deposits in systemic lupus erythematosus. Kidney Int. 2 (1972) 33-50
16. Appel G.B., Silva F.G., Pirani C.L., Meltzer J.I., and Estes D. Renal involvement in systemic lupus erythematosus (SLE): a study of fifty-six patients emphasizing histologic classification. Medicine 57 (1978) 371-410
17. Sinniah R., and Feng P.H. Lupus nephritis: correlation between light, electron microscopic and immunofluorescent findings and renal function. Clin Nephrol. 6 (1976) 340-351
18. Wilson C.B. Animal models of immunologic renal diseases. In: Neilson E.G., and Couser W.G. (Eds). Immunologic renal diseases (1997), Lippincott-Raven, Philadelphia 729-773
19. Hill G.S., Delahousse M., Nochy D., Tomkiewicz E., Rémy P., Mignon F., et al. A new morphologic index for evaluation of renal biopsies in lupus nephritis. Kidney Int. 58 (2000) 1160-1173
20. Ichiryu M.S., and Magil A.B. Intraglomerular monocyte infiltration and immune deposits in diffuse lupus glomerulonephritis. Am J Kidney Dis. 33 (1999) 866-871
21. Najafi C.C., Korbet S.M., Lewis E.J., Schwartz M.M., Reichlin M., and Evans J. Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int. 59 (2001) 2156-2163
22. Mittal B., Hurwitz S., Rennke H., and Singh A.K. New subcategories of class IV lupus nephritis: are there clinical, histologic, and outcome differences. Am J Kidney Dis. 44 (2004) 1050-1059
23. Hill G.S., Delahousse M., Nochy D., and Bariety J. Class IV-S versus class IV-G lupus nephritis: clinical and morphologic differences suggesting different pathogenesis. Kidney Int. 68 (2005) 2288-2297
24. Couser W.G. Mediation of immune glomerular injury. J Am Soc Nephrol. 1 (1990) 13-29
25. Kerjaschki D. Pathogenetic concepts of membranous glomerulopathy (MGN). J Nephrol. 13 Suppl 3 (2000) S96-S100
26. Jennette J.C. Antineutrophil cytoplasmic autoantibody-associated diseases: a pathologist's perspective. Am J Kidney Dis. 18 (1991) 164-170
27. Schwartz M.M., Lan S.P., Bonsib S.M., Gephardt G.N., Sharma H.M., and Lupus Nephritis Collaborative Study Group. Clinical outcome of three discrete histologic patterns of injury in severe lupus glomerulonephritis. Am J Kidney Dis. 13 (1989) 273-283
28. Schwartz M.M., Roberts J.L., and Lewis E.J. Necrotizing glomerulitis of systemic lupus erythematosus. Hum Pathol. 14 (1983) 158-167
29. Chin H.J., Ahn C., Lim C.S., Chung H.K., Lee J.G., Song Y.W., et al. Clinical implications of antineutrophil cytoplasmic antibody test in lupus nephritis. Am J Nephrol. 20 (2000) 57-63
30. Zhao M.H., Liu N., Zhang Y.K., and Wang H.Y. Antineutrophil cytoplasmic autoantibodies (ANCA) and their target antigens in Chinese patients with lupus nephritis. Nephrol Dial Transplant. 13 (1998) 2821-2824
31. Pradhan V.D., Badakere S.S., Bichile L.S., and Almeida A.F. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. J Assoc Physicians India 52 (2004) 533-537
32. Kant K.S., Pollak V.E., Weiss M.A., Glueck H.I., Miller M.A., and Hess E.V. Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance. Medicine 60 (1981) 71-86
33. Hamasaki K., Mimura T., Kanda H., Kubo K., Setoguchi K., Satoh T., et al. Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case report and literature review. Clin Rheumatol. 22 (2003) 355-358
34. Nzerue C.M., Hewan-Lowe K., Pierangeli S., and Harris E.N. "Black swan in the kidney": renal involvement in the antiphospholipid antibody syndrome. Kidney Int. 62 (2002) 733-744
35. Gungor T., Furlan M., Lammle B., Kuhn F., and Seger R.A. Acquired deficiency of von Willebrand factor-cleaving protease in a patient suffering from acute systemic lupus erythematosus. Rheumatology (Oxford) 40 (2001) 940-942
36. Mannucci P.M., Vanoli M., Forza I., Canciani M.T., and Scorza R. Von Willebrand factor cleaving protease (ADAMTS-13) in 123 patients with connective tissue diseases (systemic lupus erythematosus and systemic sclerosis). Haematologica 88 (2003) 914-918
37. Rieger M., Mannucci P.M., Kremer Hovinga J.A., Herzog A., Gerstenbauer G., Konetschny C., et al. ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases. Blood 106 (2005) 1262-1267
38. Dube G.K., Markowitz G.S., Radhakrishnan J., Appel G.B., and D'Agati V.D. Minimal change disease in systemic lupus erythematosus. Clin Nephrol. 57 (2002) 120-126
39. Hertig A., Droz D., Lesavre P., Grunfeld J.P., and Rieu P. SLE and idiopathic nephrotic syndrome: coincidence or not. Am J Kidney Dis. 40 (2002) 1179-1184
40. Kraft S.W., Schwartz M.M., Korbet S.M., and Lewis E.J. Glomerular podocytopathy in patients with systemic lupus erythematosus. J Am Soc Nephrol. 16 (2005) 175-179
41. Laurinavicius A., Hurwitz S., and Rennke H.G. Collapsing glomerulopathy in HIV and non-HIV patients: a clinicopathological and follow-up study. Kidney Int. 56 (1999) 2203-2213
42. Shalhoub R.J. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 2 (1974) 556-560
43. Koyama A., Fujisaki M., Kobayashi M., Igarashi M., and Narita M. A glomerular permeability factor produced by human T cell hybridomas. Kidney Int. 40 (1991) 453-460
44. Cunard R., and Kelly C.J. T cells and minimal change disease. J Am Soc Nephrol. 13 (2002) 1409-1411
45. Yap H.K., Cheung W., Murugasu B., Sim S.K., Seah C.C., and Jordan S.C. Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse. J Am Soc Nephrol. 10 (1999) 529-537
46. van den Berg J.G., Aten J., Annink C., Ravesloot J.H., Weber E., and Weening J.J. Interleukin-4 and -13 promote basolateral secretion of H(+) and cathepsin L by glomerular epithelial cells. Am J Physiol Renal Physiol. 282 (2002) F26-F33
47. Korbet S.M., Schwartz M.M., and Lewis E.J. Recurrent nephrotic syndrome in renal allografts. Am J Kidney Dis. 11 (1988) 270-276
48. Trachtman H., Greenbaum L.A., McCarthy E.T., Sharma M., Gauthier B.G., Frank R., et al. Glomerular permeability activity: prevalence and prognostic value in pediatric patients with idiopathic nephrotic syndrome. Am J Kidney Dis. 44 (2004) 604-610
49. McCarthy E.T., Sharma M., Sharma R., Falk R.J., and Jennette J.C. Sera from patients with collapsing focal segmental glomerulosclerosis increase albumin permeability of isolated glomeruli. J Lab Clin Med. 143 (2004) 225-229
50. Wüthrich R.P., Jevnikar A.M., and Kelley V.R. Understanding lupus nephritis: unraveling the pathogenesis through molecular approaches in murine models. In: Lewis E.J., Schwartz M.M., and Korbet S.M. (Eds). Lupus nephritis (1999), Oxford University Press, New York 103-125
51. Lewis E.J., Hunsicker L.G., Rohde R.D., Lachin J.M., and Lupus Nephritis Collaborative Study Group. A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. N Engl J Med. 326 (1992) 1373-1379
52. Yokoyama H., Wada T., Hara A., Yamahana J., Nakaya I., Kobayashi M., et al. The outcome and a new ISN/RPS 2003 classification of lupus nephritis in Japanese. Kidney Int. 66 (2004) 2382-2388
53. Schwartz M.M., Kawala K.S., Corwin H.L., and Lewis E.J. The prognosis of segmental glomerulonephritis in systemic lupus erythematosus. Kidney Int. 32 (1987) 274-279
54. Schwartz M.M., Bernstein J., Hill G.S., Holley K., Phillips E.A., and The Lupus Nephritis Collaborative Study Group. Predictive value of renal pathology in diffuse proliferative lupus glomerulonephritis. Kidney Int. 36 (1989) 891-896